25 XP   0   0   10

89bio Inc
Buy, Hold or Sell?

Let's analyse 89bio together

PenkeI guess you are interested in 89bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of 89bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about 89bio Inc

I send you an email if I find something interesting about 89bio Inc.

Quick analysis of 89bio (30 sec.)










What can you expect buying and holding a share of 89bio? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
9.5%

What is your share worth?

Current worth
$5.74
Expected worth in 1 year
$9.85
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
$4.11
Return On Investment
46.3%

For what price can you sell your share?

Current Price per Share
$8.88
Expected price per share
$6.88 - $14.03
How sure are you?
50%

1. Valuation of 89bio (5 min.)




Live pricePrice per Share (EOD)

$8.88

Intrinsic Value Per Share

$-17.80 - $-20.99

Total Value Per Share

$-12.06 - $-15.26

2. Growth of 89bio (5 min.)




Is 89bio growing?

Current yearPrevious yearGrowGrow %
How rich?$536.3m$121.8m$336.7m73.4%

How much money is 89bio making?

Current yearPrevious yearGrowGrow %
Making money-$49.3m-$25.5m-$23.7m-48.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of 89bio (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#102 / 1016

Most Revenue
#952 / 1016

Most Profit
#890 / 1016

Most Efficient
#397 / 1016

What can you expect buying and holding a share of 89bio? (5 min.)

Welcome investor! 89bio's management wants to use your money to grow the business. In return you get a share of 89bio.

What can you expect buying and holding a share of 89bio?

First you should know what it really means to hold a share of 89bio. And how you can make/lose money.

Speculation

The Price per Share of 89bio is $8.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of 89bio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in 89bio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.74. Based on the TTM, the Book Value Change Per Share is $1.03 per quarter. Based on the YOY, the Book Value Change Per Share is $0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of 89bio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.43-4.8%-0.38-4.3%-0.27-3.1%-0.24-2.7%-0.23-2.6%
Usd Book Value Change Per Share1.3515.2%1.0311.6%0.070.8%0.303.3%0.273.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.3515.2%1.0311.6%0.070.8%0.303.3%0.273.1%
Usd Price Per Share11.17-15.20-6.38-14.14-13.47-
Price to Earnings Ratio-6.49--10.19--5.90--18.22--17.36-
Price-to-Total Gains Ratio8.28--123.31--405.76--183.01--183.01-
Price to Book Ratio1.95-3.17-4.64-9.06-8.63-
Price-to-Total Gains Ratio8.28--123.31--405.76--183.01--183.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.88
Number of shares112
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.030.30
Usd Total Gains Per Share1.030.30
Gains per Quarter (112 shares)115.1433.08
Gains per Year (112 shares)460.54132.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104614510132122
209219120265254
30138213730397386
40184218340529518
50230322950662650
60276327560794782
70322432170926914
8036843678010591046
9041454139011911178
10046054600013231310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.021.00.00.0%0.021.00.00.0%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%6.015.00.028.6%6.015.00.028.6%
Dividend per Share1.00.03.025.0%1.00.011.08.3%2.00.018.010.0%2.00.019.09.5%2.00.019.09.5%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%6.015.00.028.6%6.015.00.028.6%

Fundamentals of 89bio

About 89bio Inc

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California.

Fundamental data was last updated by Penke on 2024-04-11 07:10:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of 89bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit 89bio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare 89bio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 89bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--197.2%+197.2%
TTM--210.4%+210.4%
YOY--279.3%+279.3%
5Y--436.8%+436.8%
10Y--599.3%+599.3%
1.1.2. Return on Assets

Shows how efficient 89bio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 89bio to the Biotechnology industry mean.
  • -6.7% Return on Assets means that 89bio generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 89bio Inc:

  • The MRQ is -6.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.7%TTM-9.8%+3.0%
TTM-9.8%YOY-15.5%+5.7%
TTM-9.8%5Y-20.1%+10.3%
5Y-20.1%10Y-21.1%+1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.7%-13.6%+6.9%
TTM-9.8%-12.9%+3.1%
YOY-15.5%-11.9%-3.6%
5Y-20.1%-14.2%-5.9%
10Y-21.1%-16.2%-4.9%
1.1.3. Return on Equity

Shows how efficient 89bio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 89bio to the Biotechnology industry mean.
  • -7.5% Return on Equity means 89bio generated $-0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 89bio Inc:

  • The MRQ is -7.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.5%TTM-10.9%+3.4%
TTM-10.9%YOY-22.6%+11.7%
TTM-10.9%5Y-18.8%+7.9%
5Y-18.8%10Y-17.9%-0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-17.0%+9.5%
TTM-10.9%-16.1%+5.2%
YOY-22.6%-15.4%-7.2%
5Y-18.8%-20.0%+1.2%
10Y-17.9%-21.1%+3.2%

1.2. Operating Efficiency of 89bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient 89bio is operating .

  • Measures how much profit 89bio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 89bio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 89bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM--224.4%+224.4%
YOY--288.4%+288.4%
5Y--475.2%+475.2%
10Y--624.7%+624.7%
1.2.2. Operating Ratio

Measures how efficient 89bio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of 89bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.997-2.997
TTM-3.247-3.247
YOY-3.766-3.766
5Y-5.675-5.675
10Y-7.857-7.857

1.3. Liquidity of 89bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if 89bio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 20.04 means the company has $20.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of 89bio Inc:

  • The MRQ is 20.044. The company is very able to pay all its short-term debts. +2
  • The TTM is 19.446. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ20.044TTM19.446+0.598
TTM19.446YOY6.645+12.801
TTM19.4465Y13.288+6.158
5Y13.28810Y12.779+0.509
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.0443.930+16.114
TTM19.4464.251+15.195
YOY6.6455.436+1.209
5Y13.2886.045+7.243
10Y12.7796.363+6.416
1.3.2. Quick Ratio

Measures if 89bio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare 89bio to the Biotechnology industry mean.
  • A Quick Ratio of 28.42 means the company can pay off $28.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 89bio Inc:

  • The MRQ is 28.421. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 26.704. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ28.421TTM26.704+1.717
TTM26.704YOY10.250+16.453
TTM26.7045Y18.191+8.513
5Y18.19110Y17.447+0.743
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.4213.629+24.792
TTM26.7044.065+22.639
YOY10.2505.397+4.853
5Y18.1915.993+12.198
10Y17.4476.277+11.170

1.4. Solvency of 89bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of 89bio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare 89bio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that 89bio assets are financed with 10.1% credit (debt) and the remaining percentage (100% - 10.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of 89bio Inc:

  • The MRQ is 0.101. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.102. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.102-0.002
TTM0.102YOY0.292-0.190
TTM0.1025Y0.343-0.241
5Y0.34310Y0.442-0.099
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1010.332-0.231
TTM0.1020.334-0.232
YOY0.2920.268+0.024
5Y0.3430.366-0.023
10Y0.4420.390+0.052
1.4.2. Debt to Equity Ratio

Measures if 89bio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare 89bio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 11.2% means that company has $0.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 89bio Inc:

  • The MRQ is 0.112. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.114. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.112TTM0.114-0.002
TTM0.114YOY0.443-0.329
TTM0.1145Y0.192-0.078
5Y0.19210Y0.183+0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1120.381-0.269
TTM0.1140.390-0.276
YOY0.4430.334+0.109
5Y0.1920.434-0.242
10Y0.1830.466-0.283

2. Market Valuation of 89bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings 89bio generates.

  • Above 15 is considered overpriced but always compare 89bio to the Biotechnology industry mean.
  • A PE ratio of -6.49 means the investor is paying $-6.49 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 89bio Inc:

  • The EOD is -5.159. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.489. Based on the earnings, the company is expensive. -2
  • The TTM is -10.192. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.159MRQ-6.489+1.330
MRQ-6.489TTM-10.192+3.702
TTM-10.192YOY-5.899-4.293
TTM-10.1925Y-18.223+8.032
5Y-18.22310Y-17.356-0.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.159-2.315-2.844
MRQ-6.489-2.560-3.929
TTM-10.192-2.664-7.528
YOY-5.899-4.122-1.777
5Y-18.223-6.258-11.965
10Y-17.356-6.108-11.248
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of 89bio Inc:

  • The EOD is -6.052. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.613. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.048. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.052MRQ-7.613+1.561
MRQ-7.613TTM-11.048+3.435
TTM-11.048YOY-7.202-3.846
TTM-11.0485Y-21.692+10.644
5Y-21.69210Y-20.659-1.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.052-3.067-2.985
MRQ-7.613-3.251-4.362
TTM-11.048-3.545-7.503
YOY-7.202-5.595-1.607
5Y-21.692-8.315-13.377
10Y-20.659-8.708-11.951
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of 89bio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.95 means the investor is paying $1.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of 89bio Inc:

  • The EOD is 1.548. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.947. Based on the equity, the company is underpriced. +1
  • The TTM is 3.167. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.548MRQ1.947-0.399
MRQ1.947TTM3.167-1.220
TTM3.167YOY4.643-1.476
TTM3.1675Y9.061-5.893
5Y9.06110Y8.629+0.431
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5481.905-0.357
MRQ1.9472.111-0.164
TTM3.1672.095+1.072
YOY4.6432.836+1.807
5Y9.0613.443+5.618
10Y8.6293.794+4.835
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of 89bio Inc.

3.1. Institutions holding 89bio Inc

Institutions are holding 106.407% of the shares of 89bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC12.21051.99181141694800
2023-12-31HHG PLC9.53480.059489151414885938121.2631
2023-12-31RTW INVESTMENTS, LLC5.96670.9734557893155789310
2023-12-31BlackRock Inc5.83330.001654541964879569.8255
2023-12-31State Street Corporation5.77460.00295399358109271825.3729
2023-12-31Suvretta Capital Management, LLC5.22822.46874888434219403081.4291
2023-12-31Pictet Asset Manangement SA4.87450.0562455768066972617.2257
2023-12-31Vanguard Group Inc4.6070.0011430758578180322.1739
2023-12-31Adage Capital Partners Gp LLC3.34220.07233125000142658383.9949
2023-09-30Holocene Advisors, LP2.39120.15112235805-402694-15.2622
2023-12-31Federated Hermes Inc2.0990.05441962566-167035-7.8435
2023-09-30Bvf Inc1.97450.7687184615400
2023-12-31Westfield Capital Management Company, LP1.88360.1147176114844926234.2455
2023-09-30BRAIDWELL LP1.70090.776159038715903870
2023-09-30Citadel Advisors Llc1.60850.005150400941965338.7007
2023-12-31Morgan Stanley - Brokerage Accounts1.59280.00151489260889506148.3118
2023-12-31Geode Capital Management, LLC1.47350.00161377710837226.4701
2023-12-31Goldman Sachs Group Inc1.350.00131262224743550143.3559
2023-09-30Octagon Capital Advisors LP1.30392.892121915715237314.2834
2023-09-30LAURION CAPITAL MANAGEMENT LP1.28940.1136120563847863265.836
Total 76.039110.507371097331+21355041+30.0%

3.2. Funds holding 89bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28SPDR® S&P Biotech ETF4.11630.59333848775485601.2778
2024-02-29Vanguard Total Stock Mkt Idx Inv2.58550.0018241746300
2024-02-29Janus Henderson Glb Life Scn I2 USD2.39140.6446223600349254828.2513
2023-12-31Janus Henderson Global Life Sciences D2.19680.466220540751101454115.6235
2023-12-31Janus Henderson Global Life Sciences2.19680.468420540751101454115.6235
2024-03-28iShares Russell 2000 ETF2.06770.034419333119330.0483
2023-12-31Pictet-Biotech P USD1.79621.18761679480308671.8723
2023-12-31Janus Selection Global Life Science AUSD1.63860.46281532140805634110.8916
2023-12-31Federated Hermes Kaufmann Small Cap A1.32480.329123866622670022.4019
2023-12-31Federated Hermes Kaufmann Small Cap Grow1.32480.329123866622670022.4019
2023-12-31Janus Henderson US SMID Cap Growth1.30090.2001121639412163940
2023-12-31Janus Henderson Triton D1.30090.1992121639412163940
2023-12-31Pictet-Global Megatrend Sel I USD1.21260.1009113384010874210.608
2023-11-30MEDICAL BioHealth EUR Acc1.02421.177595761015325119.0526
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.01370.0107947833-927-0.0977
2024-01-31Harbor Small Cap Growth Instl0.99220.718292771016036920.8993
2023-12-31Westfield Capital Mgt Co Sm-Cap Gr Eq0.82070.682876734110039115.0523
2023-12-31Federated Hermes Kaufmann R0.75560.1618706500-383235-35.1677
2023-12-31Federated Hermes Kaufmann Growth0.75560.1618706500-383235-35.1677
2023-12-31Orchard US Small Cap Value USD Instl 10.74492.493469646900
Total 31.560210.423529509245+6222994+21.1%

3.3. Insider Transactions

Insiders are holding 0.886% of the shares of 89bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-04Ra Capital Management, L.p.BUY135000015.35
2024-02-26Rohan PalekarSELL447710.76
2023-07-17Kathleen LaporteSELL1250018.8
2023-06-05Rohan PalekarSELL1500020
2023-06-01Edward Morrow Atkinson IiiSELL625017.91
2023-05-09Quoc Le-nguyenSELL1368318.11

4. Summary

4.1. Key Performance Indicators

The key performance indicators of 89bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.3491.028+31%0.069+1849%0.295+357%0.273+394%
Book Value Per Share--5.7364.905+17%1.303+340%1.921+199%1.821+215%
Current Ratio--20.04419.446+3%6.645+202%13.288+51%12.779+57%
Debt To Asset Ratio--0.1010.102-2%0.292-66%0.343-71%0.442-77%
Debt To Equity Ratio--0.1120.114-2%0.443-75%0.192-42%0.183-39%
Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Eps---0.430-0.380-12%-0.273-37%-0.238-45%-0.229-47%
Free Cash Flow Per Share---0.367-0.345-6%-0.217-41%-0.192-48%-0.185-50%
Free Cash Flow To Equity Per Share--1.3681.027+33%0.098+1292%0.300+356%0.289+374%
Gross Profit Margin--1.0001.000+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---20.993--------
Intrinsic Value_10Y_min---17.796--------
Intrinsic Value_1Y_max---1.182--------
Intrinsic Value_1Y_min---1.160--------
Intrinsic Value_3Y_max---4.253--------
Intrinsic Value_3Y_min---4.046--------
Intrinsic Value_5Y_max---8.171--------
Intrinsic Value_5Y_min---7.524--------
Market Cap830290656.000-26%1044408404.0001420984487.000-27%596303903.000+75%1322293970.400-21%1259327590.857-17%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.548-26%1.9473.167-39%4.643-58%9.061-79%8.629-77%
Pe Ratio-5.159+21%-6.489-10.192+57%-5.899-9%-18.223+181%-17.356+167%
Price Per Share8.880-26%11.17015.198-27%6.378+75%14.142-21%13.469-17%
Price To Free Cash Flow Ratio-6.052+21%-7.613-11.048+45%-7.202-5%-21.692+185%-20.659+171%
Price To Total Gains Ratio6.585-26%8.283-123.311+1589%-405.758+4999%-183.012+2310%-183.012+2310%
Quick Ratio--28.42126.704+6%10.250+177%18.191+56%17.447+63%
Return On Assets---0.067-0.098+45%-0.155+129%-0.201+198%-0.211+212%
Return On Equity---0.075-0.109+45%-0.226+201%-0.188+150%-0.179+138%
Total Gains Per Share--1.3491.028+31%0.069+1849%0.295+357%0.273+394%
Usd Book Value--536306000.000458582750.000+17%121833250.000+340%179571750.000+199%170256095.238+215%
Usd Book Value Change Per Share--1.3491.028+31%0.069+1849%0.295+357%0.273+394%
Usd Book Value Per Share--5.7364.905+17%1.303+340%1.921+199%1.821+215%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps---0.430-0.380-12%-0.273-37%-0.238-45%-0.229-47%
Usd Free Cash Flow---34297000.000-32297500.000-6%-20274250.000-41%-17955000.000-48%-17256904.762-50%
Usd Free Cash Flow Per Share---0.367-0.345-6%-0.217-41%-0.192-48%-0.185-50%
Usd Free Cash Flow To Equity Per Share--1.3681.027+33%0.098+1292%0.300+356%0.289+374%
Usd Market Cap830290656.000-26%1044408404.0001420984487.000-27%596303903.000+75%1322293970.400-21%1259327590.857-17%
Usd Price Per Share8.880-26%11.17015.198-27%6.378+75%14.142-21%13.469-17%
Usd Profit---40235000.000-49368500.000+23%-25585500.000-36%-24843000.000-38%-23880857.143-41%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--1.3491.028+31%0.069+1849%0.295+357%0.273+394%
 EOD+2 -6MRQTTM+20 -12YOY+23 -75Y+19 -1310Y+19 -13

4.2. Fundamental Score

Let's check the fundamental score of 89bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.159
Price to Book Ratio (EOD)Between0-11.548
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than128.421
Current Ratio (MRQ)Greater than120.044
Debt to Asset Ratio (MRQ)Less than10.101
Debt to Equity Ratio (MRQ)Less than10.112
Return on Equity (MRQ)Greater than0.15-0.075
Return on Assets (MRQ)Greater than0.05-0.067
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of 89bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.158
Ma 20Greater thanMa 5010.556
Ma 50Greater thanMa 10010.986
Ma 100Greater thanMa 20010.638
OpenGreater thanClose9.150
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -350110-240-354-59447-547737190



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets596,269
Total Liabilities59,963
Total Stockholder Equity536,306
 As reported
Total Liabilities 59,963
Total Stockholder Equity+ 536,306
Total Assets = 596,269

Assets

Total Assets596,269
Total Current Assets593,534
Long-term Assets2,735
Total Current Assets
Cash And Cash Equivalents 316,161
Short-term Investments 262,709
Other Current Assets 14,664
Total Current Assets  (as reported)593,534
Total Current Assets  (calculated)593,534
+/-0
Long-term Assets
Property Plant Equipment 2,339
Long-term Assets Other 396
Long-term Assets  (as reported)2,735
Long-term Assets  (calculated)2,735
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities29,611
Long-term Liabilities30,352
Total Stockholder Equity536,306
Total Current Liabilities
Short-term Debt 496
Accounts payable 8,585
Other Current Liabilities 20,530
Total Current Liabilities  (as reported)29,611
Total Current Liabilities  (calculated)29,611
+/-0
Long-term Liabilities
Long term Debt 24,795
Capital Lease Obligations Min Short Term Debt1,817
Long-term Liabilities Other 3,740
Long-term Liabilities  (as reported)30,352
Long-term Liabilities  (calculated)30,352
+/-0
Total Stockholder Equity
Common Stock93
Retained Earnings -457,432
Accumulated Other Comprehensive Income 190
Other Stockholders Equity 993,455
Total Stockholder Equity (as reported)536,306
Total Stockholder Equity (calculated)536,306
+/-0
Other
Capital Stock93
Cash and Short Term Investments 578,870
Common Stock Shares Outstanding 80,697
Liabilities and Stockholders Equity 596,269
Net Debt -289,053
Net Invested Capital 561,101
Net Working Capital 563,923
Property Plant and Equipment Gross 2,339
Short Long Term Debt Total 27,108



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
> Total Assets 
0
11,369
22,347
22,347
18,354
95,553
87,689
76,562
223,428
211,074
198,654
181,711
168,056
162,422
135,765
147,595
200,580
196,824
494,319
492,511
460,111
596,269
596,269460,111492,511494,319196,824200,580147,595135,765162,422168,056181,711198,654211,074223,42876,56287,68995,55318,35422,34722,34711,3690
   > Total Current Assets 
0
11,316
22,027
22,027
16,588
95,326
87,413
75,291
222,538
210,202
197,936
180,573
157,358
161,982
135,409
146,568
199,854
196,080
493,630
491,874
459,526
593,534
593,534459,526491,874493,630196,080199,854146,568135,409161,982157,358180,573197,936210,202222,53875,29187,41395,32616,58822,02722,02711,3160
       Cash And Cash Equivalents 
0
11,234
21,919
21,919
16,188
93,360
85,532
68,199
219,153
204,654
189,650
35,714
157,358
150,745
54,889
60,618
72,401
55,255
350,930
245,441
251,926
316,161
316,161251,926245,441350,93055,25572,40160,61854,889150,745157,35835,714189,650204,654219,15368,19985,53293,36016,18821,91921,91911,2340
       Short-term Investments 
0
0
0
0
0
0
0
5,697
77,602
106,446
121,618
135,249
117,638
98,288
71,197
78,707
120,940
132,905
129,953
232,554
196,378
262,709
262,709196,378232,554129,953132,905120,94078,70771,19798,288117,638135,249121,618106,44677,6025,6970000000
       Other Current Assets 
0
59
108
84
362
1,966
1,857
1,371
3,360
5,548
8,286
9,585
9,678
11,237
9,323
7,243
6,513
7,920
12,747
13,879
11,222
14,664
14,66411,22213,87912,7477,9206,5137,2439,32311,2379,6789,5858,2865,5483,3601,3711,8571,96636284108590
   > Long-term Assets 
0
53
0
320
1,766
227
276
1,271
890
872
718
1,138
10,698
440
356
1,027
726
744
689
637
585
2,735
2,7355856376897447261,02735644010,6981,1387188728901,2712762271,7663200530
       Property Plant Equipment 
0
33
46
46
49
155
204
191
177
166
161
154
146
150
138
230
508
455
400
348
296
2,339
2,339296348400455508230138150146154161166177191204155494646330
       Other Assets 
0
0
274
274
1,717
72
72
1,080
713
706
557
984
874
290
218
797
218
289
0
289
0
0
0028902892187972182908749845577067131,08072721,71727427400
> Total Liabilities 
0
27,426
3,624
9,537
72,325
5,609
7,787
6,791
9,424
8,113
8,459
9,006
21,286
36,465
33,024
67,410
48,005
44,992
48,489
50,525
49,902
59,963
59,96349,90250,52548,48944,99248,00567,41033,02436,46521,2869,0068,4598,1139,4246,7917,7875,60972,3259,5373,62427,4260
   > Total Current Liabilities 
0
4,353
3,624
9,537
22,579
5,609
7,787
6,791
9,424
8,113
8,459
7,580
19,845
19,537
18,400
26,899
34,423
24,614
24,015
25,944
25,212
29,611
29,61125,21225,94424,01524,61434,42326,89918,40019,53719,8457,5808,4598,1139,4246,7917,7875,60922,5799,5373,6244,3530
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500
5,000
7,604
6,835
168
171
173
176
496
4961761731711686,8357,6045,0002,5000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500
5,000
7,500
6,667
0
0
0
0
0
000006,6677,5005,0002,5000000000000000
       Accounts payable 
0
1,509
968
968
3,571
989
4,055
3,070
4,086
2,065
4,521
1,915
12,526
6,843
4,421
4,907
14,151
12,502
16,727
10,715
10,903
8,585
8,58510,90310,71516,72712,50214,1514,9074,4216,84312,5261,9154,5212,0654,0863,0704,0559893,5719689681,5090
       Other Current Liabilities 
0
2,844
0
8,569
19,008
4,620
3,732
3,721
5,338
6,048
3,938
5,665
7,319
10,194
8,979
14,388
13,437
11,944
7,117
15,056
14,133
20,530
20,53014,13315,0567,11711,94413,43714,3888,97910,1947,3195,6653,9386,0485,3383,7213,7324,62019,0088,56902,8440
   > Long-term Liabilities 
0
23,073
0
0
49,746
49,746
0
0
0
0
0
1,426
1,441
16,928
14,624
40,511
13,582
20,378
24,474
24,581
24,690
30,352
30,35224,69024,58124,47420,37813,58240,51114,62416,9281,4411,4260000049,74649,7460023,0730
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
1,426
1,441
0
0
12,050
12,958
19,691
24,332
24,483
0
0
0024,48324,33219,69112,95812,050001,4411,42600000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
30
151
28,461
395
501
0
0
0
0
000050139528,461151300000000000000
       Deferred Long Term Liability 
0
0
204
204
1,628
0
0
700
600
600
500
900
700
200
0
0
0
0
0
0
0
0
00000000200700900500600600700001,62820420400
> Total Stockholder Equity
0
-16,057
-35,358
12,810
-53,971
89,944
79,902
69,771
214,004
202,961
190,195
172,705
146,770
125,957
102,741
80,185
152,575
151,832
445,830
441,986
410,209
536,306
536,306410,209441,986445,830151,832152,57580,185102,741125,957146,770172,705190,195202,961214,00469,77179,90289,944-53,97112,810-35,358-16,0570
   Common Stock
0
1
11
8
1
14
14
14
20
20
20
20
20
20
20
20
44
51
73
75
75
93
9375757351442020202020202020141414181110
   Retained Earnings Total Equity00-382,472-344,079-315,243-290,641-263,83600-186,929-158,600-137,877-123,095000000000
   Accumulated Other Comprehensive Income 
0
-6
0
0
-16,016
-23
-23
0
-3
-10
-3
4
6
-64
-256
-318
-440
-350
-240
-594
-547
190
190-547-594-240-350-440-318-256-6464-3-10-30-23-23-16,01600-60
   Capital Surplus 
0
0
0
219
341
163,526
164,028
0
0
326,046
328,055
331,281
333,673
0
0
344,319
443,612
467,374
790,076
824,977
0
0
00824,977790,076467,374443,612344,31900333,673331,281328,055326,04600164,028163,526341219000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
124
0
48,390
341
163,549
164,028
165,668
324,501
326,046
328,055
331,281
333,673
339,218
341,759
344,319
443,612
467,374
790,076
824,977
827,878
993,455
993,455827,878824,977790,076467,374443,612344,319341,759339,218333,673331,281328,055326,046324,501165,668164,028163,54934148,39001240



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-273
Gross Profit-273-273
 
Operating Income (+$)
Gross Profit-273
Operating Expense-150,931
Operating Income-151,204-151,204
 
Operating Expense (+$)
Research Development122,230
Selling General Administrative28,974
Selling And Marketing Expenses273
Operating Expense150,931151,477
 
Net Interest Income (+$)
Interest Income13,293
Interest Expense-3,586
Other Finance Cost-887
Net Interest Income8,820
 
Pretax Income (+$)
Operating Income-151,204
Net Interest Income8,820
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-138,322-164,086
EBIT - interestExpense = -154,790
-138,322
-138,603
Interest Expense3,586
Earnings Before Interest and Taxes (EBIT)-151,204-134,736
Earnings Before Interest and Taxes (EBITDA)-150,931
 
After tax Income (+$)
Income Before Tax-138,322
Tax Provision-16
Net Income From Continuing Ops-126,556-138,338
Net Income-142,189
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses151,204
Total Other Income/Expenses Net12,882-8,820
 

Technical Analysis of 89bio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of 89bio. The general trend of 89bio is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine 89bio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of 89bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.17 < 13.71 < 14.03.

The bearish price targets are: 7.47 > 7.28 > 6.88.

Tweet this
89bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of 89bio Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

89bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of 89bio Inc. The current macd is -0.60967628.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 89bio price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for 89bio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the 89bio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
89bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart89bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of 89bio Inc. The current adx is 20.88.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell 89bio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
89bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of 89bio Inc. The current sar is 10.49.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
89bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of 89bio Inc. The current rsi is 29.16. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
89bio Inc Daily Relative Strength Index (RSI) Chart89bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of 89bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 89bio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
89bio Inc Daily Stochastic Oscillator Chart89bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of 89bio Inc. The current cci is -166.40895943.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
89bio Inc Daily Commodity Channel Index (CCI) Chart89bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of 89bio Inc. The current cmo is -61.14258438.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
89bio Inc Daily Chande Momentum Oscillator (CMO) Chart89bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of 89bio Inc. The current willr is -99.26432723.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
89bio Inc Daily Williams %R Chart89bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of 89bio Inc.

89bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of 89bio Inc. The current atr is 0.62617903.

89bio Inc Daily Average True Range (ATR) Chart89bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of 89bio Inc. The current obv is 33,806,226.

89bio Inc Daily On-Balance Volume (OBV) Chart89bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of 89bio Inc. The current mfi is 27.18.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
89bio Inc Daily Money Flow Index (MFI) Chart89bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for 89bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

89bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of 89bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.158
Ma 20Greater thanMa 5010.556
Ma 50Greater thanMa 10010.986
Ma 100Greater thanMa 20010.638
OpenGreater thanClose9.150
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of 89bio with someone you think should read this too:
  • Are you bullish or bearish on 89bio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about 89bio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about 89bio Inc

I send you an email if I find something interesting about 89bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about 89bio Inc.

Receive notifications about 89bio Inc in your mailbox!